Celyad Oncology SA (EBR: CYAD)
Belgium
· Delayed Price · Currency is EUR
0.430
-0.020 (-4.34%)
Jan 31, 2025, 5:35 PM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €17.81 million as of January 31, 2025. Its market cap has increased by 21.47% in one year.
Market Cap
17.81M
Enterprise Value
12.57M
Revenue
72.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.43
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 17.81M, a decrease of -82.53%. That is a compound annual growth rate of -13.98%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
argenx SE | 39.07B |
UCB SA | 35.71B |
Financière de Tubize | 6.80B |
Fagron NV | 1.40B |
Ion Beam Applications | 391.03M |
Nyxoah | 379.50M |
Onward Medical | 283.84M |
Hyloris Pharmaceuticals | 150.64M |